Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Montoro

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 30, 2006
[The Royal Decree on clinical trials reaches the age of 2]J B Montoro Ronsano
American Journal of Hospital Pharmacy|November 1, 1991
Comment on stability of ranitidine hydrochloride in total nutrient admixturesJ B Montoro, L Pou
European Journal of Clinical Pharmacology|January 1, 1997
Comparative study of four different pharmacokinetic computer programs: case study of a factor VIII preparationB Pascual, J B Montoro
Current Pharmaceutical Biotechnology|October 8, 2003
Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of actionC Ibáñez, J B Montoro-Ronsano
Lancet (London, England)|July 5, 2003
Role of a research ethics committee in follow-up and publication of resultsP Suñe-Martin, J B Montoro-Ronsano
The Annals of Pharmacotherapy|December 1, 1996
Comment: compatibility of amphotericin B with lipid emulsionsJ B Montoro, R M López, L Pou
Medicina Clinica|November 27, 1993
[Zidovudine pharmacokinetics]S Sanz, C Altisent, J B Montoro, et al.
JAMA|January 1, 1997
Dose of non-heat-treated factor VIII concentrate and HIV-1 RNA levelsJ B Montoro, J Oliveras, C Altisent, et al.
Lancet (London, England)|May 18, 1991
Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIIIJ B Montoro, S Rodríguez, C Altisent, et al.
Sangre|June 1, 1991
[Porcine factor VIII]M J De Juan, J B Montoro, J M Tusell
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 30, 2006
[The Royal Decree on clinical trials reaches the age of 2]J B Montoro Ronsano
American Journal of Hospital Pharmacy|November 1, 1991
Comment on stability of ranitidine hydrochloride in total nutrient admixturesJ B Montoro, L Pou
European Journal of Clinical Pharmacology|January 1, 1997
Comparative study of four different pharmacokinetic computer programs: case study of a factor VIII preparationB Pascual, J B Montoro
Current Pharmaceutical Biotechnology|October 8, 2003
Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of actionC Ibáñez, J B Montoro-Ronsano
Lancet (London, England)|July 5, 2003
Role of a research ethics committee in follow-up and publication of resultsP Suñe-Martin, J B Montoro-Ronsano
The Annals of Pharmacotherapy|December 1, 1996
Comment: compatibility of amphotericin B with lipid emulsionsJ B Montoro, R M López, L Pou
Medicina Clinica|November 27, 1993
[Zidovudine pharmacokinetics]S Sanz, C Altisent, J B Montoro, et al.
JAMA|January 1, 1997
Dose of non-heat-treated factor VIII concentrate and HIV-1 RNA levelsJ B Montoro, J Oliveras, C Altisent, et al.
Lancet (London, England)|May 18, 1991
Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIIIJ B Montoro, S Rodríguez, C Altisent, et al.
Sangre|June 1, 1991
[Porcine factor VIII]M J De Juan, J B Montoro, J M Tusell
Pageof 5